Peter Wolpert
CEO
Moberg Pharma
Sweden
Biography
Peter Wolpert, CEO and founder, M.Sc. Eng., M.Sc. Econ. Born 1969. Has worked for the company since 2006. Peter Wolpert has more than 15 years' experience as a CEO, strategy consultant and entrepreneur, and is chairman of the board of Viscogel AB. He was a co-founder of Accuro Immunology, Ibility and Viscogel, CEO of Athera Biotechnologies and a strategy consultant at McKinsey & Co. Shareholding: 435 399 shares through Wolco Invest AB and 125 000 employee stock options (125 000 shares may be subscribed to, based on the employee stock options)
Research Interest
Biotechnologies
